Microba Life Sciences (ASX:MAP) Total Assets : A$65.24 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Total Assets?

Microba Life Sciences's Total Assets for the quarter that ended in Dec. 2023 was A$65.24 Mil.

During the past 12 months, Microba Life Sciences's average Total Assets Growth Rate was 283.90% per year.

Total Assets is connected with ROA %. Microba Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 was -40.96%. Total Assets is also linked to Revenue through Asset Turnover. Microba Life Sciences's Asset Turnover for the quarter that ended in Dec. 2023 was 0.06.

Microba Life Sciences Total Assets Historical Data

The historical data trend for Microba Life Sciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Total Assets Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Total Assets

39.48

46.95

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	43.69	39.48	51.64	46.95	65.24

Microba Life Sciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Microba Life Sciences's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	38.574	+	8.379
	=	46.95

Microba Life Sciences's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	49.248	+	15.988
	=	65.24

Microba Life Sciences (ASX:MAP) Total Assets Explanation

Total Assets is connected with ROA %.

Microba Life Sciences's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-22.976	/	( (46.953	+	65.236)	/ 2 )
	=	-22.976	/	56.0945
	=	-40.96 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Microba Life Sciences's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	3.273	/	( (46.953	+	65.236)	/ 2 )
=	3.273	/	56.0945
=	0.06

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Microba Life Sciences Total Assets Related Terms

Thank you for viewing the detailed overview of Microba Life Sciences's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Microba Life Sciences (ASX:MAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.

Microba Life Sciences (ASX:MAP) Headlines

No Headlines